Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies
André Scheen
Topics & Concepts
MedicineStroke (engine)Observational studyInternal medicineRandomized controlled trialAtrial fibrillationPlaceboType 2 diabetesDiabetes mellitusCohortCohort studyIntensive care medicineEndocrinologyPathologyAlternative medicineMechanical engineeringEngineeringDiabetes Treatment and ManagementGastroesophageal reflux and treatmentsNeuropeptides and Animal Physiology